Dexmedetomidine improved renal function in patients with severe sepsis: an exploratory analysis of a randomized controlled trial

Dexmedetomidine improved renal function in patients with severe sepsis: an exploratory analysis of a randomized controlled trial

Abstract Background Dexmedetomidine has been reported to improve organ dysfunction in critically ill patients. In a recent randomized controlled trial (Dexmedetomidine for Sepsis in Intensive Care Unit (ICU) Randomized Evolution [DESIRE]), we demonstrated that dexmedetomidine was associated with red...

Full description

Bibliographic Details
Main Authors: Tsuyoshi Nakashima, Kyohei Miyamoto, Nozomu Shima, Seiya Kato, Yu Kawazoe, Yoshinori Ohta, Takeshi Morimoto, Hitoshi Yamamura, DESIRE Trial Investigators
Format: Article
Language:English
Published: BMC 2020-01-01
Series:Journal of Intensive Care
Subjects:
Dexmedetomidine
Sequential organ failure assessment score
Acute kidney injury
Septic shock
Sedation
Online Access:https://doi.org/10.1186/s40560-019-0415-z

Internet

https://doi.org/10.1186/s40560-019-0415-z

Similar Items